Likewise, we have previously demonstrated that decreased vasostatin-2, a peptide derived from chromogranin A possessing pronounced anti-inflammatory and anti-atherogenic actives, was associated with chronic heart failure and incidence of major adverse cardiac events during a 3-year follow-up (30). Here, CHGA is linked to congestive heart failure.